PRODUCT

GLP-3 20mg

70,00 €

FOR RESEARCH USE ONLY, NOT FOR HUMAN CONSUMPTION

No reviews yet

Unavailable · expected back around Aug 31, 2026

EU shipping Bitcoin payment Live stock status

DESCRIPTION

Product description

GLP-3 20mg

Retatrutide is a once-weekly, acylated triple-agonist peptide that activates GLP-1, GIP, and glucagon receptors. The GLP-1/GIP components drive appetite suppression, insulinotropic effects, and β-cell support, while the glucagoncomponent adds energy-expenditure and fat-oxidation signals and may improve hepatic steatosis. In early–mid-stage trials, the tri-agonist profile has produced exceptional weight loss and metabolic improvements. Retatrutide is investigational (not FDA/EMA-approved).